Header cover image

Canadian (TSX) Biotech Industry Analysis

UpdatedMar 19, 2024
DataAggregated Company Financials
Companies30
  • 7D-0.04%
  • 3M2.5%
  • 1Y-24.0%
  • YTD-3.6%

Over the last 7 days, the Biotech industry has dropped 2.4%, driven by a pullback from Spectral Medical of 16%. Meanwhile, Medicenna Therapeutics actually outperformed within the industry, gaining 34% in the last week. Overall the industry is down 26% in 12 months. Looking forward, earnings are forecast to grow by 38% annually.

Industry Valuation and Performance

Has the Canadian Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 19 Mar 2024CA$1.1bCA$91.6m-CA$320,217,123.8111.1x-3.6x12.4x
Thu, 15 Feb 2024CA$1.1bCA$87.2m-CA$323,735,872.7710.4x-3.3x12.4x
Sat, 13 Jan 2024CA$3.6bCA$86.2m-CA$516,247,702.006.8x-6.9x41.3x
Mon, 11 Dec 2023CA$3.8bCA$86.1m-CA$543,138,347.005.6x-6.9x43.7x
Wed, 08 Nov 2023CA$3.8bCA$88.9m-CA$542,970,944.007.8x-6.9x42.2x
Fri, 06 Oct 2023CA$3.8bCA$89.0m-CA$526,162,468.006.1x-7.3x43x
Sun, 03 Sep 2023CA$4.0bCA$90.0m-CA$513,801,240.006.1x-7.8x44.7x
Tue, 01 Aug 2023CA$4.0bCA$81.9m-CA$515,977,162.007.2x-7.8x48.9x
Thu, 29 Jun 2023CA$4.0bCA$86.4m-CA$549,244,562.0013x-7.2x46x
Sat, 27 May 2023CA$3.8bCA$86.9m-CA$608,188,765.0011.1x-6.3x43.9x
Mon, 24 Apr 2023CA$3.7bCA$83.8m-CA$598,401,888.0012.3x-6.2x44.6x
Wed, 22 Mar 2023CA$2.6bCA$90.4m-CA$620,392,824.009.3x-4.3x29.3x
Fri, 17 Feb 2023CA$2.9bCA$89.1m-CA$589,658,227.008.6x-4.9x32.7x
Sun, 15 Jan 2023CA$3.1bCA$87.5m-CA$525,283,764.0011.6x-5.8x34.9x
Tue, 13 Dec 2022CA$3.3bCA$88.6m-CA$579,676,215.007.1x-5.6x36.8x
Thu, 10 Nov 2022CA$3.1bCA$86.0m-CA$566,604,054.0014.8x-5.4x35.6x
Sat, 08 Oct 2022CA$3.1bCA$86.1m-CA$549,676,132.0014.7x-5.7x36.4x
Mon, 05 Sep 2022CA$3.6bCA$84.6m-CA$537,622,667.0013x-6.7x42.7x
Wed, 03 Aug 2022CA$3.3bCA$87.3m-CA$563,558,453.0011.3x-5.8x37.6x
Fri, 01 Jul 2022CA$3.1bCA$181.2m-CA$609,994,015.0011.5x-5.1x17.3x
Sun, 29 May 2022CA$3.2bCA$179.4m-CA$606,213,701.0015.6x-5.2x17.7x
Tue, 26 Apr 2022CA$3.4bCA$176.4m-CA$491,566,556.0014.3x-6.9x19.2x
Thu, 24 Mar 2022CA$3.2bCA$170.7m-CA$490,742,226.0013.9x-6.6x19x
Sat, 19 Feb 2022CA$3.5bCA$168.0m-CA$455,384,834.0017.3x-7.7x20.8x
Mon, 17 Jan 2022CA$3.4bCA$166.4m-CA$429,998,987.0019.6x-7.9x20.3x
Wed, 15 Dec 2021CA$5.9bCA$165.3m-CA$494,744,660.0010.1x-12x35.9x
Fri, 12 Nov 2021CA$6.1bCA$172.2m-CA$449,880,289.007.2x-13.5x35.2x
Sun, 10 Oct 2021CA$7.9bCA$240.5m-CA$608,032,848.008.1x-13.1x33x
Tue, 07 Sep 2021CA$8.1bCA$222.8m-CA$562,923,623.087.2x-14.5x36.5x
Thu, 05 Aug 2021CA$3.5bCA$161.7m-CA$474,887,008.0826.8x-7.4x21.7x
Sun, 09 May 2021CA$4.4bCA$154.4m-CA$492,315,138.3116x-8.9x28.3x
Price to Earnings Ratio

-10.2x


Total Market Cap: CA$4.7bTotal Earnings: -CA$464,148,726.31Total Revenue: CA$154.6mTotal Market Cap vs Earnings and Revenue0%0%0%
Canadian Biotech Industry Price to Earnings3Y Average -7.4x202220232024
Current Industry PE
  • Investors are pessimistic on the Canadian Biotechs industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 32.7x is higher than the industry's current PS ratio of 12.3x.
Past Earnings Growth
  • The earnings for companies in the Biotechs industry have improved over the last three years.
  • Meanwhile revenues for these companies have declined 16% per year.
  • This means that less sales are being generated overall, but since the cost of doing business is lower, losses have been shrinking.

Industry Trends

Which industries have driven the changes within the Canadian Healthcare industry?

CA Market0.24%
Healthcare13.73%
Biotech-0.044%
Biotech-0.044%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
MDNA Medicenna TherapeuticsCA$1.5334.2%
+CA$27.2m
101.3%PB5.7x
SVA SernovaCA$0.6011.1%
+CA$18.2m
-31.8%PB14.5x
METX ME Therapeutics HoldingsCA$3.3624.0%
+CA$15.4m
n/an/a
EPRX Eupraxia PharmaceuticalsCA$4.55-22.2%
CA$2.0m
13.8%PB9.5x
ACOG Alpha CognitionCA$0.901.1%
+CA$1.5m
200.0%PE-8.2x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

GLAB

CA$0.46

Gemina Laboratories

7D

-8.0%

1Y

-31.3%

EDT

CA$0.42

Spectral Medical

7D

-16.0%

1Y

25.4%

EPRX

CA$4.55

Eupraxia Pharmaceuticals

7D

-22.2%

1Y

13.8%

METX

CA$3.36

ME Therapeutics Holdings

7D

24.0%

1Y

n/a

MDNA

CA$1.53

Medicenna Therapeutics

7D

34.2%

1Y

101.3%

SBM

CA$0.07

Sirona Biochem

7D

-12.5%

1Y

-22.2%

PSYG

CA$0.035

Psyence Group

7D

-30.0%

1Y

-73.1%

NAV

CA$0.06

NAVCO Pharmaceuticals

7D

71.4%

1Y

n/a

ACOG

CA$0.90

Alpha Cognition

7D

1.1%

1Y

200.0%

KNE

CA$0.10

Kane Biotech

7D

10.5%

1Y

-8.7%

SVA

CA$0.60

Sernova

7D

11.1%

1Y

-31.8%

CYTO

CA$0.48

Cytophage Technologies

7D

-11.1%

1Y

-3.5%

BCT

CA$3.91

BriaCell Therapeutics

7D

-3.2%

1Y

-59.2%

DRUG

CA$1.80

Bright Minds Biosciences

7D

-16.3%

1Y

-41.9%

DTC

CA$1.72

Defence Therapeutics

7D

-9.5%

1Y

-54.6%

AEZS

CA$2.85

Aeterna Zentaris

7D

9.2%

1Y

-19.7%